Prevalence and Correlates of Elevated NT-proBNP in Pregnant Women in the General U.S. Population-Reference-Cited by-同舟云学术

Prevalence and Correlates of Elevated NT-proBNP in Pregnant Women in the General U.S. Population

Published:2023-03 Issue:2 Volume:2 Page:100265
ISSN:2772-963X
Container-title:JACC: Advances
language:en
Short-container-title:JACC: Advances

Author:

Minhas Anum S.^ORCID,Rooney Mary R.^ORCID,Fang Michael,Zhang Sui,Ndumele Chiadi E.,Tang Olive,Schulman Steven P.,Michos Erin D.^ORCID,McEvoy J. William,Echouffo-Tcheugui Justin B.^ORCID,Christenson Robert,Selvin Elizabeth

Publisher

Elsevier BV

Reference38 articles.

1. Births: final data for 2018;Martin;Natl Vital Stat Rep,2019

2. NT-ProBNP: the mechanism behind the marker;Hall;J Card Fail,2005

3. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

4. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

5. N-terminal pro–B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study;Corteville;Arch Intern Med,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence–based screening for cardiomyopathy in an obstetric population: A pilot study;Cardiovascular Digital Health Journal;2024-06

2. Early-pregnancy N-terminal pro-brain natriuretic peptide level is inversely associated with hypertensive disorders of pregnancy diagnosed after 35 weeks of gestation;Scientific Reports;2024-05-28

3. Stretch-induced compliance mechanism in pregnancy-induced cardiac hypertrophy and the impact of cardiovascular risk factors;American Journal of Physiology-Heart and Circulatory Physiology;2024-05-01

4. Genetic Associations of Circulating Cardiovascular Proteins With Gestational Hypertension and Preeclampsia;JAMA Cardiology;2024-03-01

5. Cardiovascular risk evaluation in pregnancy: focus on cardiac specific biomarkers;Clinical Chemistry and Laboratory Medicine (CCLM);2023-11-10